The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker). This is the first time the agency has approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated
from Food and Drug Administration--Press Releases http://ift.tt/2rNjR8y
via IFTTT
No comments:
Post a Comment